We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Sacklers and Purdue Reach Settlement as Opioids Crisis Continues
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Sacklers and Purdue Reach Settlement as Opioids Crisis Continues
Sacklers and Purdue Reach Settlement as Opioids Crisis Continues
Health

Sacklers and Purdue Reach Settlement as Opioids Crisis Continues

Last updated: March 4, 2022 3:14 pm
Editorial Board Published March 4, 2022
Share
SHARE
00sackler deal facebookJumbo

After hundreds of hours of negotiations mediated by Judge Shelley Chapman of federal bankruptcy court, the Sacklers also agreed to a series of other new terms. In addition to the Sackler statement, which Mr. Tong characterized as an “apology,” Judge Chapman is recommending a hearing that would allow people who suffered from addiction to OxyContin to describe what they had endured, and that family members from each of two Sackler branches attend. And another condition under the deal: If any medical centers and art or educational institutions bearing the Sackler name want it removed, the family cannot contest the request.

Under the plan, Purdue would be renamed Knoa Pharma and overseen by a public board. The restructured, public benefit company would contribute funds for the plaintiffs’ programs, plus more as Knoa evolved into a manufacturer of medications for addiction reversal and treatment, among other drugs, including OxyContin.

The new settlement, however, still faces a hurdle before it can go forward. The U.S. Trustee program, which serves as a watchdog over the bankruptcy system within the Department of Justice, has long argued strenuously against the proposed immunity shield for the Sacklers. Before the tentative deal on Thursday, a battle had been building in the U.S. Court of Appeals for the Second Circuit, which had said it would take up the matter on an expedited basis.

The Justice Department declined to comment on whether it would continue to challenge that condition of the tentative settlement.

As marathon sessions of negotiations dragged on, the opioid crisis continued to deepen, with overdoses soaring during the pandemic. The dilemma for the holdout governments was whether to keep pursuing the Sacklers in court, a process that could take years with no guarantee of victory, or just take the money, now that the cash offer had increased.

While all the states and, in turn, their local governments, would get a bigger payout than the original deal outlined, the holdout states would get even more, as a bonus for their resistance. The $750 million set aside to compensate more than 100,000 individual victims and survivors, whose stories help build the governmental lawsuits, would not grow, but states have committed to funding an “opioid survivors trust” specifically for them.

Ryan Hampton, who monitored years of proceedings on behalf of those affected by the opioid epidemic, said: “At least the $750 million is being protected which is better than no money at all. This bankruptcy needs to end. And the Justice Department needs to flex their muscle and investigate the Sacklers criminally, which is permissible under the bankruptcy plan.”

You Might Also Like

Research finds key gene loss could set off untimely getting old within the mind

Weight problems prevalence would shift considerably underneath proposed new standards, research finds

Steady glucose screens are in vogue. However do you really want to trace your blood sugar?

What’s chikungunya virus, and may we be apprehensive about it in Australia?

Texts about more healthy consuming might assist forestall childhood weight problems

TAGGED:BankruptciesCompensation for Damages (Law)Deaths (Fatalities)Drug Abuse and TrafficOffice of the United States TrusteeOpioids and OpiatesOxyContin (Drug)Pain-Relieving DrugsPurdue PharmaSackler FamilyStates (US)Suits and Litigation (Civil)The Washington Mailyour-feed-healthcare
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
‘Renaissance’ Review: America Has a Problem and Beyoncé Ain’t It
Entertainment

‘Renaissance’ Review: America Has a Problem and Beyoncé Ain’t It

Editorial Board July 31, 2022
Perennial Flowers and Vegetation That Present Lasting Magnificence to Your Residence.
Republicans Once Silent on Russia Ratchet Up Attacks on Biden
Mayor Adams agrees to not publicly criticize Trump as Day One govt orders rock NYC, nation
NYC Council leaders weighing authorized motion to dam Mayor Adams’ new ICE enforcement coverage

You Might Also Like

New analysis uncovers gene impacts of PFAS publicity in firefighters
Health

New analysis uncovers gene impacts of PFAS publicity in firefighters

July 26, 2025
Injured as soon as, triggered ceaselessly? How the mind rewrites stress responses
Health

Injured as soon as, triggered ceaselessly? How the mind rewrites stress responses

July 26, 2025
Microscopy reveals how Hippo pathway proteins management gene exercise in most cancers
Health

Microscopy reveals how Hippo pathway proteins management gene exercise in most cancers

July 26, 2025
Mind peptide ODN reduces starvation and boosts glucose regulation in rat research
Health

Mind peptide ODN reduces starvation and boosts glucose regulation in rat research

July 26, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?